Samer Kaba's Insider Trades & SAST Disclosures

Samer Kaba's most recent trade in Alimera Sciences Inc. was a trade of 18,750 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 7, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alimera Sciences Inc.
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 18,750 18,750 - - Employee Stock Option (Right to Buy)
Alimera Sciences Inc.
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 6,250 14,929 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades